logotype
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us
logotype
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us
logotype
logotype
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us
August 10, 2022
by info@virtueinsight.comNews0 Comments

GSK Acquires Bellus Health for $2 Billion

  GSK plc (LSE/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) today announced that they have entered into an agreement under which GSK will acquire BELLUS, a Canada-based, late-stage...
read more
September 5, 2022
by info@virtueinsight.comNews0 Comments

Juno Pharmaceuticals Acquires Omega Laboratories

  Juno Pharmaceuticals Canada (“Juno”), a leader in the commercialization of specialty pharmaceuticals, announced the acquisition of Omega Laboratories (“Omega”), one of Canada’s largest...
read more
February 14, 2023
by info@virtueinsight.comNews0 Comments

EyePoint to sell YUTIQ to Alimera Sciences

      EyePoint Pharmaceuticals (NASDAQ:EYPT) entered into a definitive agreement for the sale of YUTIQ (fluocinolone acetonide intravitreal implant) 0.18mg to Alimera Sciences. YUTIQ...
read more
February 14, 2023
by info@virtueinsight.comNews0 Comments

Spanish packaging firm Inden Pharma to expand footprint in India

  Spanish packaging firm Inden Pharma is planning to expand its business to India after partnering with Austria-based ALPLApharma that specialises in plastic packaging for pharmaceuticals. In a...
read more
June 5, 2023
by info@virtueinsight.comNews0 Comments

GSK Acquires Bellus Health for $2 Billion

  GSK plc (LSE/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) today announced that they have entered into an agreement under which GSK will acquire BELLUS, a Canada-based, late-stage...
read more
June 5, 2023
by info@virtueinsight.comNews0 Comments

Juno Pharmaceuticals Acquires Omega Laboratories

  Juno Pharmaceuticals Canada (“Juno”), a leader in the commercialization of specialty pharmaceuticals, announced the acquisition of Omega Laboratories (“Omega”), one of Canada’s largest...
read more
June 5, 2023
by info@virtueinsight.comNews0 Comments

EyePoint to sell YUTIQ to Alimera Sciences

      EyePoint Pharmaceuticals (NASDAQ:EYPT) entered into a definitive agreement for the sale of YUTIQ (fluocinolone acetonide intravitreal implant) 0.18mg to Alimera Sciences. YUTIQ...
read more
  • 1
  • 2
  • 3
  • …
  • 9

Recent Posts

  • BioNTech to Acquire CureVac for $1.25 Billion
  • Eli Lilly acquires SiteOne Therapeutics
  • Sanofi buys Vigil Neuroscience for $470m in Alzheimer’s push
  • Novo Holdings completes Catalent acquisition for $16.5bn
  • AbbVie buys Nimble Therapeutics for $200M

Recent Comments

No comments to show.

Archives

  • June 2025
  • December 2024
  • November 2024
  • August 2024
  • July 2024
  • May 2024
  • March 2024
  • February 2024
  • January 2024
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • February 2023
  • September 2022
  • August 2022

Categories

  • News
Categories
  • News62
Popular Tags
anticounterfeit anticounterfeiting Bigdata biosimilars biotech biotechnology brandprotection clinicalresearch clinicaltrials Counterfeit cro drugsafety DSCSA healthcare Healthtech medical pharma pharmaceutical pharmaceutical pharma pharmacovigilance pharmaindustry PharmaNews pharmareglatory pharmaregulatory regulatoryaffairs serialazation Serialization supplychain supplychainsecurity traceability trackandtrace VirtueInsight
Gallery
logotype

We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.

Facebook-fTwitterYoutubeLinkedin-inInstagramPinterest

Quick Links

About us
Contact us
Event Support
Careers
Privacy Policy
Terms & Conditions

Subscribe to our newsletter

    © 2025 Virtue Insight. All rights reserved.